Toward engineering a novel transplantation site for human pancreatic islets

Diabetes

Volumn 62, Issue 5, 2013, Pages 1357-1364

  Smink, Alexandra M ^a   Faas, Marijke M ^a   De Vos, Paul ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; FIBRIN; FIBRINOGEN; FIBRONECTIN; GAMMA INTERFERON; GLUCOSE; GRANULOCYTE CHEMOTACTIC PROTEIN 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; THROMBIN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ALLOIMMUNITY; AUTOIMMUNITY; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINE PRODUCTION; DIABETIC PATIENT; EPITHELIAL MESENCHYMAL TRANSITION; GLUCOSE METABOLISM; GRAFT FAILURE; HUMAN; INNATE IMMUNITY; INSULIN RELEASE; LIVER FIBROSIS; LIVER PARENCHYMA; LIVER TRANSPLANTATION; LONG TERM CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OUTCOME ASSESSMENT; OXYGEN TENSION; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVASCULARIZATION; REVIEW; STOMACH MUCOSA; THROMBOSIS;

ANIMALS; BIOMEDICAL RESEARCH; DIABETES MELLITUS, TYPE 1; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HETEROTOPIC;

EID: 84876568501     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-1553     Document Type: Review

References (50)

1. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006;355:1318-1330 (Pubitemid 44465460)
2. Barton FB, Rickels MR, Alejandro R, et al. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 2012;35:1436-1445
3. Harlan DM, Kenyon NS, Korsgren O, Roep BO; Immunology of Diabetes Society. Current advances and travails in islet transplantation. Diabetes 2009;58:2175-2184
4. Korsgren O, Lundgren T, Felldin M, et al. Optimising islet engraftment is critical for successful clinical islet transplantation. Diabetologia 2008;51:227-232
5. Carlsson PO, Palm F, Andersson A, Liss P. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 2001;50:489-495 (Pubitemid 32195212)
6. O'Sullivan ES, Johnson AS, Omer A, et al. Rat islet cell aggregates are superior to islets for transplantation in microcapsules. Diabetologia 2010;53:937-945
7. Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 1998;55:1139-1149 (Pubitemid 28206701)
8. Sun S, Ning X, Zhang Y, et al. Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney Int 2009;75:1278-1287
9. Moberg L, Johansson H, Lukinius A, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002;360:2039-2045 (Pubitemid 36026584)
10. van der Windt DJ, Bottino R, Casu A, Campanile N, Cooper DK. Rapid loss of intraportally transplanted islets: an overview of pathophysiology and preventive strategies. Xenotransplantation 2007;14:288-297 (Pubitemid 47174365)
11. Cowley MJ, Weinberg A, Zammit N, et al. Human islets express a marked pro-inflammatory molecular signature prior to transplantation. Cell Transplant 2012;21:2063-2078
12. Johansson U, Olsson A, Gabrielsson S, Nilsson B, Korsgren O. Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. Biochem Biophys Res Commun 2003;308:474-479 (Pubitemid 36945516)
13. Piemonti L, Leone BE, Nano R, et al. Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 2002;51:55-65 (Pubitemid 34517980)
14. Lacotte S, Berney T, Shapiro AJ, Toso C. Immune monitoring of pancreatic islet graft: towards a better understanding, detection and treatment of harmful events. Expert Opin Biol Ther 2011;11:55-66
15. Bosi E, Braghi S, Maffi P, et al. Autoantibody response to islet transplantation in type 1 diabetes. Diabetes 2001;50:2464-2471 (Pubitemid 33642763)
16. Hilbrands R, Huurman VA, Gillard P, et al. Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients. Diabetes 2009;58:2267-2276
17. Toyofuku A, Yasunami Y, Nabeyama K, et al. Natural killer T-cells participate in rejection of islet allografts in the liver of mice. Diabetes 2006;55:34-39 (Pubitemid 43348456)
18. Stagner JI, Rilo HL, White KK. The pancreas as an islet transplantation site. Confirmation in a syngeneic rodent and canine autotransplant model. JOP 2007;8:628-636 (Pubitemid 47484622)
19. Caiazzo R, Gmyr V, Hubert T, et al. Evaluation of alternative sites for islet transplantation in the minipig: interest and limits of the gastric submucosa. Transplant Proc 2007;39:2620-2623 (Pubitemid 47588380)
20. Svensson J, Lau J, Sandberg M, Carlsson PO. High vascular density and oxygenation of pancreatic islets transplanted in clusters into striated muscle. Cell Transplant 2011;20:783-788
21. Fritschy WM, van Straaten JF, de Vos P, Strubbe JH, Wolters GH, van Schilfgaarde R. The efficacy of intraperitoneal pancreatic islet isografts in the reversal of diabetes in rats. Transplantation 1991;52:777-783
22. Ao Z, Matayoshi K, Lakey JR, Rajotte RV, Warnock GL. Survival and function of purified islets in the omental pouch site of outbred dogs. Transplantation 1993;56:524-529 (Pubitemid 23293009)
23. Cantarelli E, Melzi R, Mercalli A, et al. Bone marrow as an alternative site for islet transplantation. Blood 2009;114:4566-4574
24. Carlsson PO, Palm F, Andersson A, Liss P. Chronically decreased oxygen tension in rat pancreatic islets transplanted under the kidney capsule. Transplantation 2000;69:761-766 (Pubitemid 30174094)
25. Komori J, Boone L, DeWard A, Hoppo T, Lagasse E. The mouse lymph node as an ectopic transplantation site for multiple tissues. Nat Biotechnol 2012;30:976-983
26. Kaufman DB, Morel P, Field MJ, Munn SR, Sutherland DE. Purified canine islet autografts. Functional outcome as in fluenced by islet number and implantation site. Transplantation 1990;50:385-391 (Pubitemid 20309856)
27. Cantarelli E, Piemonti L. Alternative transplantation sites for pancreatic islet grafts. Curr Diab Rep 2011;11:364-374
28. Rafael E, Tibell A, Rydén M, et al. Intramuscular autotransplantation of pancreatic islets in a 7-year-old child: a 2-year follow-up. Am J Transplant 2008;8:458-462
29. De Vos P, Vegter D, De Haan BJ, Strubbe JH, Bruggink JE, Van Schilfgaarde R. Kinetics of intraperitoneally infused insulin in rats. Functional implications for the bioartificial pancreas. Diabetes 1996;45:1102-1107 (Pubitemid 26260164)
30. De Vos P, Hillebrands JL, De Haan BJ, Strubbe JH, Van Schilfgaarde R. Efficacy of a prevascularized expanded polytetrafluoroethylene solid support system as a transplantation site for pancreatic islets. Transplantation 1997;63:824-830 (Pubitemid 27150588)
31. Dufour JM, Rajotte RV, Zimmerman M, et al. Development of an ectopic site for islet transplantation, using biodegradable scaffolds. Tissue Eng 2005;11:1323-1331 (Pubitemid 41636419)
32. Kaido T, Yebra M, Cirulli V, Rhodes C, Diaferia G, Montgomery AM. Impact of defined matrix interactions on insulin production by cultured human beta-cells: effect on insulin content, secretion, and gene transcription. Diabetes 2006;55:2723-2729 (Pubitemid 44923670)
33. Pinkse GG, Bouwman WP, Jiawan-Lalai R, Terpstra OT, Bruijn JA, de Heer E. Integrin signaling via RGD peptides and anti-beta1 antibodies confers resistance to apoptosis in islets of Langerhans. Diabetes 2006;55:312-317 (Pubitemid 43343258)
34. Lucas-Clerc C, Massart C, Campion JP, Launois B, Nicol M. Long-term culture of human pancreatic islets in an extracellular matrix: morphological and metabolic effects. Mol Cell Endocrinol 1993;94:9-20 (Pubitemid 23213776)
35. Weber LM, Hayda KN, Haskins K, Anseth KS. The effects of cell-matrix interactions on encapsulated beta-cell function within hydrogels functionalized with matrix-derived adhesive peptides. Biomaterials 2007;28:3004-3011 (Pubitemid 46560870)
36. Robertson RP. Islet transplantation as a treatment for diabetes - a work in progress. N Engl J Med 2004;350:694-705 (Pubitemid 38364628)
37. Ludwig B, Rotem A, Schmid J, et al. Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc Natl Acad Sci USA 2012;109:5022-5027
38. Silva AI, de Matos AN, Brons IG, Mateus M. An overview on the development of a bio-artificial pancreas as a treatment of insulin-dependent diabetes mellitus. Med Res Rev 2006;26:181-222 (Pubitemid 43334641)
39. Meek MF, Coert JH. US Food and Drug Administration/Conformit Europe-approved absorbable nerve conduits for clinical repair of peripheral and cranial nerves. Ann Plast Surg 2008;60:466-472
40. Meek MF, Den Dunnen WF. Porosity of the wall of a Neurolac nerve conduit hampers nerve regeneration. Microsurgery 2009;29:473-478
41. Bulstra SK, Geesink RG, Bakker D, Bulstra TH, Bouwmeester SJ, van der Linden AJ. Femoral canal occlusion in total hip replacement using a resorbable and flexible cement restrictor. J Bone Joint Surg Br 1996;78:892-898 (Pubitemid 26392116)
42. Sakkers RJ, de Wijn JR, Dalmeyer RA, van Blitterswijk CA, Brand R. Evaluation of copolymers of polyethylene oxide and polybutylene terephthalate (polyactive): mechanical behaviour. J Mater Sci Mater Med 1998;9:375-379 (Pubitemid 28344794)
43. Van Dorp AG, Verhoeven MC, Koerten HK, Van Der Nat-Van Der Meij TH, Van Blitterswijk CA, Ponec M. Dermal regeneration in full-thickness wounds in Yucatan miniature pigs using a biodegradable copolymer. Wound Repair Regen 1998;6:556-568 (Pubitemid 128659203)
44. Roessler M, Wilke A, Griss P, Kienapfel H. Missing osteoconductive effect of a resorbable PEO/PBT copolymer in human bone defects: a clinically relevant pilot study with contrary results to previous animal studies. J Biomed Mater Res 2000;53:167-173 (Pubitemid 30171961)
45. Lembert N, Wesche J, Petersen P, et al. Encapsulation of islets in rough surface, hydroxymethylated polysulfone capillaries stimulates VEGF release and promotes vascularization after transplantation. Cell Transplant 2005;14:97-108 (Pubitemid 40604953)
46. Hakim RM, Held PJ, Stannard DC, et al. Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int 1996;50:566-570 (Pubitemid 26274386)
47. Dufrane D, Steenberghe Mv, Goebbels RM, Saliez A, Guiot Y, Gianello P. The in fluence of implantation site on the biocompatibility and survival of alginate encapsulated pig islets in rats. Biomaterials 2006;27:3201-3208 (Pubitemid 43344334)
48. Dufrane D, Goebbels RM, Gianello P. Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression. Transplantation 2010;90:1054-1062
49. Pedraza E, Brady AC, Fraker CA, et al. Macroporous three dimensional PDMS scaffolds for extrahepatic islet transplantation. Cell Transplant. 2 October 2012 [Epub ahead of print]
50. Fort A, Fort N, Ricordi C, Stabler CL. Biohybrid devices and encapsulation technologies for engineering a bioartificial pancreas. Cell Transplant 2008;17:997-1003